Indication
HIV
The HIV pipeline: 61 tracked drugs, 21 approved for this indication.
21 approved / phase 48 Phase 32 Phase 2/315 Phase 23 Phase 1/212 Phase 1
Compare the share prices of listed companies in HIV →
Total attributable cost
$59.5B
$53,945/patient
Drug spend
$46.2B
$41,834/patient
78% of total cost is drugs
All stages, diagnosed (2024 estimate) · US